SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of Changes in Restructuring Expenses Accrual


Table 2.3: Restructuring Expenses and Impairment Loss
	Statements of Operations	For the Year Ended December 31,
		2024		2023

		(in thousands)
2022 Restructuring Plan:
Severance and related benefit costs (adjustments)	SG&A	$	(10)	$	(168)
Other related costs	SG&A	—		1,300
2024 Restructuring Plan:
Severance and related benefit costs	Cost of sales	341		—
Severance and related benefit costs	R&D, SG&A	939		—
Total restructuring expenses		1,270		1,132
Impairment of intangible assets (1)	Impairment loss on intangible assets	6,373		—
Total restructuring expenses and impairment loss		$	7,643	$	1,132

(1) The recoverability evaluation of intangible assets resulted in an $11.7 million impairment loss, of which $5.3 million was recorded under cost of sales for the discontinued parts of certain solutions, and $6.4 million was recorded under operating expenses as a result of the restructuring plan (see Note 8 - Intangible Assets, Net).

At each reporting date, the Company evaluates its restructuring expense accrual to determine if the liabilities reported are still appropriate. Any changes in the estimated costs of executing the approved restructuring plan are reflected in the Company's consolidated statements of operations.


Table 2.4: Summary of Changes in Restructuring Expenses Accrual
	Severance and related benefit costs (1)

	(in thousands)
Balance at December 31, 2023	$	400
Expenses (adjustments)	1,270
Cash payments	(1,633)
Balance at December 31, 2024	$	37

(1) Restructuring-related liabilities are reported as part of "Other current liabilities" in the Company's consolidated balance sheets, see Note 9 - Other Balance Sheet Components for further details.